We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Venezuela's pricing environment remains difficult for multinationals,
but international trade associations have welcomed recent government
moves whichpartly improve the outlook.
Two new surveys have highlighted both the growing trend towards consolidationin the Indian drug sector, and its potential in developing new biotech products.
Leading domestic drug makers, including Wockhardt, Ranbaxy, Dr. Reddy's, Lupin
and Sun Pharma, have agreed to provide medicines at cost price to the poor in
return for a no-price control regime.
Leading pharmaceutical company Lupin Ltd (BSE:500257) said it was looking at
acquiring companies and brands in a bid to strengthen its paediatric business
in the US market.
Work officially began today on the construction of a new sanofi pasteur manufacturing
facility that will expand the ability of the United States to produce influenza
vaccine for both routine influenza immunization and in case of a global influenza
pandemic.
Troubled flu vaccine maker Chiron Corp. on Wednesday said it is unable to supply
a German-made flu vaccine in key European markets for the 2005-2006 season,
days after reporting it would slash production due to potential contamination
at a German plant.
In an example of a growing trend throughout Sub-Saharan
Africa, government agencies in Zanzibar and Tanzania are to begin distributing
HIV/AIDS drugs at zero cost.